Whalesbook
Aster DM Healthcare's hospitals in Kerala are operating at full capacity again following a nurses' strike that cost the company an estimated ₹5.78 crore in lost revenue. While operations have resumed thanks to court mediation, ongoing wage disputes and the potential for future labor actions highlight significant operational risks. These persistent issues may not be fully reflected in the company's high stock valuation, despite positive analyst sentiment.
Strike Resolution and Court Intervention
Nursing staff have returned to work at Aster DM Healthcare's seven Kerala facilities, restoring full operations after a directive from the Kerala High Court. The strike, initiated by the United Nurses Association (UNA) on March 9, 2026, was over demands for higher wages. The court's intervention, which deferred the strike until March 19, 2026, and was later extended to May 31, 2026, provided immediate relief and prevented further revenue losses beyond the initial ₹5.78 crore. The company expects no additional revenue loss if operations remain normal. However, court proceedings are ongoing, indicating the dispute between the Kerala Private Hospital Association (KPHA) and the UNA is not definitively settled.
Wider Labor Unrest in Kerala Healthcare
This nurses' strike is part of a larger trend of labor unrest affecting the state's healthcare sector. Other healthcare workers, including ASHA workers and government doctors, have also protested issues like late payments, limited career growth, and heavy workloads. Such ongoing labor disputes create significant risks for companies like Aster DM Healthcare with major operations in Kerala. A stable and content nursing staff is crucial for hospital efficiency, and even short disruptions can harm patient care and occupancy rates. The KPHA has also stated the strike was legally invalid due to procedural issues, adding complexity to labor relations.
Valuation Amidst Operational Risks
Aster DM Healthcare's stock currently trades at a premium. In mid-April 2026, its P/E ratio ranged from approximately 87x to 108x, significantly higher than the broader sector average of around 42.7x. With a market value of roughly ₹35,000 crore, this high valuation suggests investors expect strong future growth. Competitors such as Apollo Hospitals (P/E 59.4x), Fortis Healthcare (P/E 64.6x), and Narayana Hrudayalaya (P/E 45.2x) trade at lower multiples. This indicates that Aster DM Healthcare's valuation may not fully account for the ongoing risks from labor disputes in its key markets.
Lingering Labor Challenges
The resolution of the strike is a temporary measure, and ongoing court cases suggest potential for future disruptions. The UNA reported wage issues resolved in most hospitals, but 28 remain contested, pointing to unresolved disputes. Relying on court intervention for labor peace highlights underlying tensions that can harm operational stability. Furthermore, the company's high P/E ratio presents a risk if earnings growth falters or if more labor problems lead to significant financial damage, similar to a past hit of 27-30% to quarterly net profit. Increasing consolidation among rivals, such as the planned merger between Aster DM and Quality Care, may strengthen market position but also heightens competition and could require more investment in staff and operations, potentially squeezing profits.
Analyst Outlook
Despite these operational challenges, analysts remain optimistic. There is a 'Strong Buy' consensus rating, with an average 12-month price target of ₹700.11. Forward P/E ratios indicate expectations of earnings growth. The company is focusing on expansion in India, enhancing its digital services, and specialty care offerings. However, the success of these strategies will depend on its ability to manage labor relations effectively and reduce the financial impact of ongoing strikes in India's healthcare sector, especially in Kerala. Recent analyst adjustments to target prices suggest shifting market perceptions.